Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Asia IPO pipeline is still looking strong. This week, there were five new draft prospectus filed on Hong Kong Exchange. Refer to the "New IPO filings this week" list below for the names and estimated deal size.
Upcoming IPOs have been sparse. Joinn Laboratories (H) (6127 HK)'s H-Share debuted on Friday, falling through its IPO price as A-shares price have fallen during bookbuild while Sciclone Pharmaceuticals (6600 HK) trades on Wednesday.
Cheerwin (6601 HK) launched its IPO on Friday, looking to debut and we have looked at peer analysis, product review, and valuation in our notes this week.
Also in Hong Kong secondary listings, news reports confirmed that Autohome Inc (Adr) (ATHM US) has won approval from HKEX for its proposed secondary listing. We take a look at deal dynamics and past secondary listings performance in:
Singapore finally got another large non REIT IPO. Aztech Global (1869224D SP) is looking to IPO after its 2017 privatization. The company's fortunes changed almost right after its delisting due to a lucky break. We discuss in detail in our note:
In the U.S, we shared our earnings forecast and thoughts on valuation while waiting for Coupang (CPNG US)'s IPO bookbuild launch.
Last but not least, in the Philippines, DDMP REIT (1848316D PM) is looking to ride on the REIT wave after Areit (AyalaLand REIT) (AREIT PM)'s strong comeback in share price despite a disappointing debut.
Placements:
Our overall accuracy rate is 74% for IPOs and 67.2% for Placements
(Performance measurement criteria is explained at the end of the note)
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.